Uveal Melanoma Clinical Trials
2 recruiting trials for Uveal Melanoma. Eligibility criteria explained in plain English.
TrialFinderData lists 2 Uveal Melanoma clinical trials drawn from ClinicalTrials.gov, all of which are currently recruiting participants.
Across the trials that carry a phase, Phase 1 is the largest group at 50% (1 studies); the largest phase groups are Phase 1: 1, Phase 1 / Phase 2: 1.
Research is led by Memorial Sloan Kettering Cancer Center (1), St Vincent's Hospital, Sydney (1), among the most active sponsors registered for these trials.
The most frequently studied intervention is Lifileucel (LN-144/LN-145) (biological, 1 trial), followed by Aldesleukin.
Track Uveal Melanoma trials
Subscribe for TrialFinderData updates by email. No spam, unsubscribe anytime.
Recruiting Trials
Clinical trial data sourced from the ClinicalTrials.gov registry, maintained by the National Library of Medicine. Always consult your doctor before considering any clinical trial.
A Study of LN-144 or LN-145 in People With Advanced Uveal Melanoma, Undifferentiated Pleomorphic Sarcoma, or...
This is an open label study evaluating lifileucel (LN-144) in patients with metastatic uveal melanoma.
Adding IL-2 to Tebentafusp to Eradicate Cancer Progression
A recent clinical trial found that after 36 months, patients taking tebentafusp had a median survival of 21.6 months, compared to 16.9 months for those in the control group. Since...
Explore Other Conditions
Frequently Asked Questions
There are currently 2 clinical trials for Uveal Melanoma, with 2 actively recruiting participants. These include trials across all phases from early-stage Phase 1 to late-stage Phase 3.
To join a clinical trial for Uveal Melanoma, review the eligibility criteria on the trial detail pages, then talk to your doctor about whether a trial is right for you. Your doctor can help you evaluate the potential benefits and risks.
Phase 3 trials are large-scale studies that test whether a treatment is effective and monitor side effects. There are 0 Phase 3 trials for Uveal Melanoma, representing treatments closest to potential FDA approval.
Clinical trials follow strict safety protocols overseen by Institutional Review Boards (IRBs) and the FDA. Participants are monitored closely and can withdraw at any time. Always discuss risks and benefits with your healthcare provider before enrolling.
Trial data sourced from the ClinicalTrials.gov API. This site does not provide medical advice, always talk to your doctor about clinical trial participation.